Lafarge Ads (LFRGY) 18.1750 $LFRGY European Stocks Rise

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Lafarge Ads (LFRGY) 18.1750 $LFRGY

European Stocks Rise on U.K. Election Surprise, Bank Gains
at The Street - Fri May 08, 5:19AM CDT
U.K. stocks rallied Friday as Prime Minister David Cameron's Conservative Party won a majority. Bank stocks rose, and continental stocks were increasing too.
SYT: 87.94 (+0.04), MON: 120.32 (-0.50), RBS: 11.05 (-0.08), LYG: 5.53 (-0.10), NOK: 6.96 (+0.06)

Holcim - Lafarge Merger Vote Approaches as Regulators, Shareholders Fall in Line
at The Street - Tue May 05, 8:58AM CDT
North American regulators give their blessing to the $39 billion building materials union, while a major Holcim shareholder pledges support ahead of Friday's shareholder vote.

Holcim and Lafarge will sell some assets to complete deal
AP - Mon May 04, 6:02PM CDT
NEW YORK (AP) — Holcim and Lafarge have agreed to sell cement plants, distribution terminals and other assets in order to complete their merger, which will make the world's largest cement company.
CRH: 28.57 (-0.19)

Holcim/Lafarge merger: Competition Bureau accepts the sale of all of Holcim's operations in Canada
CNW Group - Mon May 04, 5:01PM CDT
To preserve competition for the supply of cement and related products in Canada, the Competition Bureau has reached a consent agreement with building and construction materials maker Holcim Ltd that will see it sell all of its Canadian operations and all associated assets as part of its proposed acquisition of Lafarge S.A.

Holcim, Lafarge win U.S. antitrust approval to merge
Seeking Alpha - at Seeking Alpha - Mon May 04, 3:59PM CDT


Holcim, Lafarge merger approval looking better
Seeking Alpha - at Seeking Alpha - Mon May 04, 10:01AM CDT


Holcim's Hopes for Merger With Lafarge Get a Boost From Eurocement
at The Street - Thu Apr 30, 9:01AM CDT
Russia's Eurocement Holding has thrown its weight behind the $40 billion merger of construction materials giants Holcim and Lafarge, just a week before a Holcim shareholder vote on the deal.

Wall Street Breakfast: World Stocks Remain In Sell-Off Mode
Wall Street Breakfast - at Seeking Alpha - Thu Apr 30, 5:30AM CDT

ALU: 3.77 (+0.01), BLK: 370.71 (-0.14), SNE: 32.45 (-0.29), RBS: 11.05 (-0.08), NOK: 6.96 (+0.06), ORCL: 44.24 (+0.09), YHOO: 44.36 (-0.39), SAP: 75.63 (-1.20), SPY: 213.10 (+0.66), QQQ: 110.06 (+0.48), IBM: 173.06 (-0.20), TWTR: 37.28 (+0.18), MSFT: 48.01 (-0.28), AAPL: 130.19 (+1.42), CRM: 72.80 (+0.40)

Holcim continues to pave road for Lafarge merger
Seeking Alpha - at Seeking Alpha - Thu Apr 30, 3:45AM CDT


Oldcastle - Big Moat, Interesting Company
Holmes_Osborne - at Seeking Alpha - Tue Apr 21, 2:05AM CDT

CRH: 28.57 (-0.19)

Wall Street Breakfast: Dollar Drifts Ahead Of Consumer Inflation Data
Wall Street Breakfast - at Seeking Alpha - Fri Apr 17, 5:30AM CDT

AXP: 80.17 (-0.05), SNE: 32.45 (-0.29), JBLU: 21.83 (+0.41), BA: 146.71 (-0.17), SLB: 92.75 (+0.61), MS: 38.33 (+0.48), SPY: 213.10 (+0.66), GS: 204.66 (+1.69), QQQ: 110.06 (+0.48), COST: 145.06 (+0.23), VZ: 49.60 (-0.19)

Lafarge, Holcim outline U.S. disposals as part of merger
Seeking Alpha - at Seeking Alpha - Fri Apr 17, 3:12AM CDT

SUM: 26.63 (+0.61)

Wall Street Breakfast: Nokia Confirms Advanced Merger Talks With Alcatel-Lucent
Wall Street Breakfast - at Seeking Alpha - Tue Apr 14, 5:30AM CDT

SPLS: 16.48 (+0.08), AMZN: 425.24 (-0.76), LMT: 193.08 (+0.72), HD: 114.33 (+0.98), MDT: 77.47 (+1.05), A: 42.63 (+0.59), ALU: 3.77 (+0.01), SNE: 32.45 (-0.29), WFC: 55.75 (+0.23), TM: 139.43 (+0.06), BA: 146.71 (-0.17), NOK: 6.96 (+0.06), NWSA: 15.68 (+0.13), JNJ: 103.42 (+1.12), SPY: 213.10 (+0.66), JPM: 66.42 (+0.54), QQQ: 110.06 (+0.48), EBAY: 59.46 (+0.05), IBM: 173.06 (-0.20), ODP: 9.25 (+0.07), PG: 80.74 (-0.31), AAPL: 130.19 (+1.42)

Holcim, Lafarge nominate candidates for new board
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 3:50AM CDT


European Stocks Rise; Carmakers Benefit From Optimism About a Recovery
at The Street - Thu Apr 09, 5:50AM CDT
European stock indices rose on Thursday following modest gains on Wall Street ahead of a crunch Greek debt repayment to the country's international creditors. Carmakers gained.
FCAU: 15.47 (+0.02), INFN: 20.27 (+0.56), BABA: 87.11 (-1.35)

Wall Street Breakfast: LaFarge, Holcim Name Olsen As CEO
Wall Street Breakfast - at Seeking Alpha - Thu Apr 09, 5:33AM CDT

SPY: 213.10 (+0.66), QQQ: 110.06 (+0.48), ZNGA: 2.97 (-0.08), CMCSA: 56.97 (+0.33)

Lafarge, Holcim name Olsen as CEO
Seeking Alpha - at Seeking Alpha - Thu Apr 09, 2:08AM CDT


European Stocks Rise as Confidence in Economic Recovery Grows
at The Street - Mon Mar 30, 5:34AM CDT
European stocks rose on Monday as March gains in eurozone economic sentiment and the business climate indicator added to confidence that the recovery is gathering pace.
NVS: 104.06 (+0.31)

Wall Street Breakfast: Greece Battles To Release Funds
Wall Street Breakfast - at Seeking Alpha - Mon Mar 30, 5:29AM CDT

RAI: 76.36 (-1.19), BCS: 16.36 (-0.18), ABX: 13.19 (+0.07), C: 54.67 (+0.43), LO: 71.83 (-0.33), BBY: 35.09 (+0.50), BAC: 16.51 (+0.16), RBS: 11.05 (-0.08), HPTX: 45.99 (+0.02), SPY: 213.10 (+0.66), JPM: 66.42 (+0.54), QQQ: 110.06 (+0.48), HZNP: 29.20 (+0.17), DD: 69.99 (-0.26), CVX: 106.65 (-1.38)

Holcim shareholder plans to vote against new Lafarge deal
Seeking Alpha - at Seeking Alpha - Mon Mar 30, 3:25AM CDT


Scroll down for more posts ▼

Top 10 Most Recent News Articles

2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 22

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 26

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 34

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 28

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 19

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 27

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading

Top 5 Most Recently Viewed Articles

FTI Consulting Expands Tax Advisory Team with New Experts

Updated Category News Views 199

FTI Consulting Strengthens Tax Advisory Team FTI Consulting, Inc. (NYSE: FCN) has announced the strategic enhancement of its Tax Advisory team within the EMEA region through the recruitment of two highly experienced professionals. This move reflects the company's commitment to providing top-tier advisory services amidst the complexities of the global tax environment. New...

Continue Reading
Cingulate Inc. Unveils Q1 Financial Highlights and Future Plans

Updated Category News Views 148

Cingulate Inc. Reports First Quarter Financial Results Cingulate Inc. (NASDAQ: CING), a biopharmaceutical entity known for its innovative Precision Timed Release™ (PTR™) drug delivery technology, has recently unveiled its financial results for the first quarter. The report sheds light on several important developments concerning their lead assets for ADHD and anxiety....

Continue Reading
Innovative Partnership Propels Sen-Jam Pharmaceutical's Future

Updated Category News Views 106

Strategic Partnership to Enhance Phase 3 Trial for SJP-001 In a significant move, Sen-Jam Pharmaceutical has announced a promising partnership with TASK Clinical, a renowned global contract research organization (CRO), aimed at funding two-thirds of the upcoming Phase 3 clinical trial for its lead candidate, SJP-001. This equity-backed collaboration is not only innovative...

Continue Reading
Exploring the Future of Solar Energy: Insights from EnergySage

Updated Category News Views 231

EnergySage's Solar & Storage Marketplace Report Highlights EnergySage, a trusted name in solar market analysis, has released its latest report, which delves into the current dynamics of the solar and storage marketplace. This comprehensive analysis examines trends that are influencing the future of the industry, particularly in light of recent policy shifts. Residential...

Continue Reading
Investors' Rights: Explore Possible Violations for SCS, HLVX and Others

Updated Category News Views 166

Investigation into Potential Shareholder Violations Halper Sadeh LLC, a well-known law firm advocating for investor rights, is currently investigating several companies due to potential breaches of federal securities laws and fiduciary duties to their shareholders. Steelcase Inc. (SCS) Steelcase Inc. is reportedly undergoing a transaction involving the sale to HNI...

Continue Reading